Drugmaker Novo Nordisk expects Wegovy weight-loss drug sales in the United States to start to recover once a ban on compound ...

Novo Nordisk has gone up another gear in its drive to boost manufacturing ... injectables in North Carolina, US. The new plant will be one of the largest manufacturing investments in Novo Nordisk ...

Shares of Novo Nordisk closed around 1% lower on Thursday, while Eli Lilly's stock closed more than 11% lower. It comes as Novo Nordisk works to boost access ... across the US healthcare system ...

PLAINSBORO, N.J., April 25, 2025 /PRNewswire/ -- Yesterday, a Texas federal court ruled in favor of Novo Nordisk and FDA ... it is illegal under US compounding laws to make or sell knockoff ...

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in the first head-to-head study of the blockbuster medications.

Oral pills, being more convenient than injectables, tend to boost patient adherence. Novo Nordisk also markets Rybelsus ... of the obesity market makes us believe that the setback is temporary.

Compounders quickly cranked into overdrive, manufacturing ... Steve Benz, Novo's legal chief, said in a release. "FDA's determination was based on a thorough review of Novo Nordisk's stable ...

Weight loss leader Novo Nordisk ... for Novo Nordisk as tariffs will increase prices. The company's key manufacturing facility is still in Denmark, though it does produce in the US too and with ...

In this article, we are going to take a look at where Novo Nordisk A/S ... in Brazil in a bid to boost the production of both Wegovy and Ozempic. Brazil is a major manufacturing destination ...